Stainsby Dorothy, Russell Joan, Cohen Hannah, Lilleyman John
Serious Hazards of Transfusion, Manchester Blood Centre, Manchester, UK.
Br J Haematol. 2005 Oct;131(1):8-12. doi: 10.1111/j.1365-2141.2005.05702.x.
Against a background of ever increasing expenditure on blood safety, less attention has been paid to improving the safety of the transfusion chain within hospitals. Based on reports to the Serious Hazards of Transfusion (SHOT scheme) between 1996 and 2003, the risk of an error occurring during transfusion of a blood component is estimated at 1:16 500, an ABO incompatible transfusion at 1:100 000 and the risk of death as a result of an 'incorrect blood component transfused' (IBCT) is around 1:1 500 000. There are opportunities for error at a number of critical points in the transfusion chain, starting with the decision to transfuse, prescription and request, patient sampling, pretransfusion testing and finally the collection of the component from the blood refrigerator and administration to the patient, consistently the commonest error in successive SHOT reports. Successive 'Better Blood Transfusion' initiatives and the 2003 Annual Report of the Chief Medical Officer for England have drawn welcome attention to the importance of safe and appropriate transfusion and the National Patient Safety Agency has now set a target of reducing the number of ABO incompatible transfusions by 50% over 3-5 years.
在血液安全支出不断增加的背景下,医院输血链安全的改善却较少受到关注。根据1996年至2003年向输血严重危害(SHOT计划)提交的报告,血液成分输血期间发生错误的风险估计为1:16500,ABO血型不匹配输血的风险为1:100000,因“错误输血成分”(IBCT)导致死亡的风险约为1:1500000。在输血链的多个关键点都存在出错的可能性,从输血决策、处方和申请、患者采样、输血前检测,到最后从血库冰箱中取出成分并输给患者,这一直是连续的SHOT报告中最常见的错误。连续的“改善输血”倡议以及2003年英格兰首席医疗官的年度报告,都对安全、适当输血的重要性给予了令人欢迎的关注,国家患者安全机构现已设定目标,要在3至5年内将ABO血型不匹配输血的数量减少50%。